Bristol Myers Squibb Announces Strategic Agreement with Anthropic to Position Claude Enterprise as the Shared Intelligence Platform ...

Claude will be deployed across BMS to assist with drug discovery, clinical development, regulatory submissions, manufacturing ...

BMS wants AI agents inside drug discovery, clinical trials, manufacturing and corporate work. BMS will deploy Claude across ...

The Incyte–Genesis deal pairs significant upfront capital with long-tail milestones and royalties, while granting Incyte ...

Bristol Myers Squibb (BMS) has announced a strategic agreement with Anthropic to deploy Claude across the company’s research, ...

Bristol Myers Squibb (NYSE: BMY) is deploying Claude enterprise AI across its entire global workforce. Specifically, the pharmaceutical giant is making Anthropic's Claude available to more than 30,000 ...

Claude Code is expected to standardize and accelerate software and AI development while improving access to data and ...